Aberrant DNA methylation as a cancer-inducing mechanism.
about
Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancerWnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumoursSensitive Melting Analysis after Real Time- Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detectionDevelopmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2New blood markers detection technology: A leap in the diagnosis of gastric cancerEpigenetic mechanisms involved in melanoma pathogenesis and chemoresistanceEffect of DNA Methylation in Various Diseases and the Probable Protective Role of Nutrition: A Mini-ReviewThe impact of nutrition on differential methylated regions of the genomeA perspective on dietary phytochemicals and cancer chemoprevention: oxidative stress, nrf2, and epigenomicsDietary factors and epigenetic regulation for prostate cancer preventionMechanism and function of oxidative reversal of DNA and RNA methylationTumour biomarkers: homeostasis as a novel prognostic indicatorToward precision medicine of breast cancerA human tRNA methyltransferase 9-like protein prevents tumour growth by regulating LIN9 and HIF1-αThe implications of heterogeneous DNA methylation for the accurate quantification of methylationhNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencingHigh RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcomeDNA methylation profile of 28 potential marker loci in malignant mesotheliomaPotential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesisVinclozolin exposure in utero induces postpubertal prostatitis and reduces sperm production via a reversible hormone-regulated mechanismCancer biomarker discovery: the entropic hallmark.Delineating the cytogenomic and epigenomic landscapes of glioma stem cell linesDownregulation of RUNX3 and TES by hypermethylation in glioblastoma.Dynamics of adipogenic promoter DNA methylation during clonal culture of human adipose stem cells to senescence.DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons.MeInfoText: associated gene methylation and cancer information from text mining.Assembling pieces of the centromere epigenetics puzzle.Perinatal exposure to oestradiol and bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesisEpigenetic reprogramming and imprinting in origins of diseaseAssessment of changes in the BRCA2 and P53 genes in breast invasive ductal carcinoma in northeast Brazil.Epigenetics meets endocrinology.Early detection of gastric cancer using global, genome-wide and IRF4, ELMO1, CLIP4 and MSC DNA methylation in endoscopic biopsiesMethylation status of DDIT3 gene in chronic myeloid leukemiaQuantitative detection of multiple gene promoter hypermethylation in tumor tissue, serum, and cerebrospinal fluid predicts prognosis of malignant gliomas.MethylPurify: tumor purity deconvolution and differential methylation detection from single tumor DNA methylomesDpp signaling and the induction of neoplastic tumors by caspase-inhibited apoptotic cells in Drosophila.Down-regulation of the nucleotide excision repair gene XPG as a new mechanism of drug resistance in human and murine cancer cellsClinical application of genetics in management of colorectal cancer.RGS6 suppresses Ras-induced cellular transformation by facilitating Tip60-mediated Dnmt1 degradation and promoting apoptosis.
P2860
Q21245721-C9A9BA80-88A8-4A50-AE93-74F43EBF304AQ22000774-E3205BE8-A9B3-457A-A5DE-8477E25CD9A1Q24646396-A8E0F08E-AC5A-4C14-957B-48ADCB12945EQ24648201-32536469-8891-4FD3-B9E2-309C214BFE00Q24684224-8B85874C-8897-4FC4-9C79-B6A4FC5DD1B3Q26774503-91B93632-D18B-436A-8F5A-EB0B991EE027Q26778761-E2E6AD27-F927-4A50-AC97-55746F53C33DQ26782672-70D26A73-35CF-4896-B879-6B4901C556C4Q26824826-99EC779E-5038-42D9-A48F-30816EA99EBFQ26852571-ABA676FE-8D42-462E-95DB-A1A515D28957Q26991774-7FD49BBB-76D4-479B-87AB-E5D60E6733DCQ27002361-3CFDFB18-A659-41D9-89E4-551F8E0923A6Q28069898-A128EF2F-2F2C-4D83-BA53-116109F666BBQ28073967-B0E25996-6274-4391-850E-479F5838189CQ28115094-7493F119-0DD8-4B95-A179-A9BD72EB4896Q28254096-0B7463AC-E551-4B8C-8583-86038F90EAF2Q28286594-3762D92C-CDFC-4D20-8D4D-D296658CE063Q28297992-90E1E319-3953-42D1-9B29-29FBC6DDD538Q28391214-AA9521E5-673D-423B-BC37-CFCB5A0FD6A5Q28393302-BAB65870-AA50-4B90-A659-338C314B0EFBQ28581972-1D54F583-82C1-4BA7-8810-452AD1F213C3Q30496149-7E0BD6B0-8107-4202-9896-D32C17BCA3E9Q31112229-5F61F3F9-6A2A-4671-A870-B8AA237B8839Q33253913-4F8E9577-0597-46F3-869B-4B11FA41ADAFQ33286093-099CD8D8-0FC6-4D39-B372-F964AC6EF4DDQ33299459-82F7DDFE-69F6-4C37-8993-4854EB8D816EQ33314659-78F5FA34-1387-4095-B8C6-4B655C8FAD2BQ33352751-31DF3FDC-8D80-44B5-843C-EA4077939891Q33642456-83C8501E-0760-4317-980C-9E4BCDCDE6CBQ33751081-A1E4F2B7-214C-441A-BA3B-3BDC44E93682Q33766324-CC31AC78-98D3-4378-8620-68C3A1B47BE5Q33810295-B4263E18-548B-45E4-823B-9EA827E8E97CQ33888849-EF30FF5F-1A4D-4497-B586-F2F8A5C71047Q33933648-27A60971-5658-46B7-A1D6-BA392BCD2391Q34132959-63202E52-80BC-4924-BA32-E47ACE731B40Q34193538-26391B0A-570D-4028-B151-9BB2A347DA8CQ34202032-9F6117FF-6B0E-40ED-A970-F2DB168FC0DCQ34202863-53F2FD7A-32F9-4CC3-B3E3-49C88735DE0FQ34378719-0164BB39-BB6D-4888-9531-7E84C994C28DQ34513042-57B91BF3-0C8C-40D9-9DAD-55B8F5AC561F
P2860
Aberrant DNA methylation as a cancer-inducing mechanism.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Aberrant DNA methylation as a cancer-inducing mechanism.
@ast
Aberrant DNA methylation as a cancer-inducing mechanism.
@en
Aberrant DNA methylation as a cancer-inducing mechanism.
@nl
type
label
Aberrant DNA methylation as a cancer-inducing mechanism.
@ast
Aberrant DNA methylation as a cancer-inducing mechanism.
@en
Aberrant DNA methylation as a cancer-inducing mechanism.
@nl
prefLabel
Aberrant DNA methylation as a cancer-inducing mechanism.
@ast
Aberrant DNA methylation as a cancer-inducing mechanism.
@en
Aberrant DNA methylation as a cancer-inducing mechanism.
@nl
P1476
Aberrant DNA methylation as a cancer-inducing mechanism.
@en
P304
P356
10.1146/ANNUREV.PHARMTOX.45.120403.095832
P577
2005-01-01T00:00:00Z